glp-1 receptor agonist pancreatitis risk meta-analysis Evaluating the Rates of and Pancreatic Cancer Among GLP‐1 Agonists: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials - Wen - 2025 - Endocrinology, Diabetes & Metabolism Results of cardiovascular outcomes trials
Description
Diabetes Obes Metab 2018;20(11):255764
India Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry
The review confirmed GLP-1R is expressed at high levels on -cells, where GLP-1 stimulates somatostatin secretion which in turn indirectly suppresses both glucagon and insulin through paracrine mechanisms
This extensive review demonstrates how GLP-1 RAs have transcended traditional therapeutic boundaries by modulating core cellular mechanisms, including mitochondrial enhancement, anti-inflammatory actions, autophagy-mediated quality control, and neuroprotective pathways that underlie multiple disease states
Goldstein BJ, Feinglos MN, Lunceford JK, et al
works closely with patients to evaluate medical history, lifestyle factors, and treatment goals before recommending a GLP-1 therapy
